Mayne Pharma To Pay US$650K To End US Antitrust Claim
Mayne Pharma said Monday it would pay US$650,000 (AU$927,000) to settle a complaint by 49 U.S. attorneys general alleging antitrust violations in its marketing of a generic version of the antibiotic...To view the full article, register now.
Already a subscriber? Click here to view full article